title: CT imaging of pediatric patients with cystic fibrosis on ivacaftor therapy.
authors.affiliation: Department of Pediatrics, The Ohio State University College of Medicine, Columbus, OH, USA, hayes.705@osu.edu.
authors.forename: Don
authors.initials: D
authors.lastname: Hayes
authors.forename: Frederick R
authors.initials: FR
authors.lastname: Long
authors.forename: Karen S
authors.initials: KS
authors.lastname: McCoy
authors.forename: Shahid I
authors.initials: SI
authors.lastname: Sheikh
mesh_terms: D000293:Adolescent; D000367:Age Factors; D000627:Aminophenols / Q000627:therapeutic use*; D003550:Cystic Fibrosis / Q000000981:diagnostic imaging / Q000188:drug therapy* / Q000235:genetics / Q000503:physiopathology; D019005:Cystic Fibrosis Transmembrane Conductance Regulator / Q000819:agonists / Q000235:genetics; D005541:Forced Expiratory Volume; D020022:Genetic Predisposition to Disease; D006801:Humans; D008168:Lung / Q000000981:diagnostic imaging / Q000187:drug effects* / Q000503:physiopathology; D008297:Male; D009154:Mutation; D010641:Phenotype; D011237:Predictive Value of Tests; D015363:Quinolones / Q000627:therapeutic use*; D020127:Recovery of Function; D019141:Respiratory System Agents / Q000627:therapeutic use*; D013997:Time Factors; D014057:Tomography, X-Ray Computed; D016896:Treatment Outcome; D014797:Vital Capacity
chemical_list: D000627:Aminophenols; C505032:CFTR protein, human; D015363:Quinolones; D019141:Respiratory System Agents; D019005:Cystic Fibrosis Transmembrane Conductance Regulator; C545203:ivacaftor